|
Multiple Sclerosis Clinical Trials
541 recruiting studies across 28 states and 49 cities.
Find Trials by State
California
91 trials · 7 cities
Texas
67 trials · 7 cities
Massachusetts
39 trials · 1 city
Florida
37 trials · 4 cities
New York
36 trials · 1 city
Maryland
33 trials · 1 city
District of Columbia
33 trials · 1 city
Illinois
27 trials · 1 city
Ohio
25 trials · 2 cities
Arizona
24 trials · 3 cities
Washington
18 trials · 1 city
Missouri
17 trials · 1 city
Colorado
17 trials · 2 cities
North Carolina
14 trials · 2 cities
Georgia
12 trials · 1 city
Wisconsin
12 trials · 1 city
Pennsylvania
12 trials · 1 city
Tennessee
7 trials · 2 cities
Minnesota
6 trials · 1 city
Oregon
6 trials · 1 city
Oklahoma
5 trials · 1 city
Nebraska
4 trials · 1 city
New Mexico
3 trials · 1 city
Nevada
3 trials · 1 city
Indiana
2 trials · 1 city
Kentucky
2 trials · 1 city
Louisiana
1 trials · 1 city
Virginia
1 trials · 1 city
Find Trials by City
Boston, MA
39 trials
New York, NY
36 trials
Baltimore, MD
33 trials
Washington, DC
33 trials
Chicago, IL
27 trials
San Francisco, CA
23 trials
San Jose, CA
22 trials
Seattle, WA
18 trials
Kansas City, MO
17 trials
Long Beach, CA
17 trials
Los Angeles, CA
17 trials
Denver, CO
16 trials
Tampa, FL
15 trials
Cleveland, OH
14 trials
Houston, TX
14 trials
Arlington, TX
13 trials
Dallas, TX
13 trials
Fort Worth, TX
13 trials
Atlanta, GA
12 trials
Milwaukee, WI
12 trials
Philadelphia, PA
12 trials
Columbus, OH
11 trials
Raleigh, NC
11 trials
Mesa, AZ
10 trials
Phoenix, AZ
10 trials
Orlando, FL
9 trials
San Diego, CA
9 trials
Miami, FL
8 trials
Austin, TX
7 trials
Minneapolis, MN
6 trials
Portland, OR
6 trials
Jacksonville, FL
5 trials
Oklahoma City, OK
5 trials
Memphis, TN
4 trials
Omaha, NE
4 trials
San Antonio, TX
4 trials
Tucson, AZ
4 trials
Albuquerque, NM
3 trials
Charlotte, NC
3 trials
El Paso, TX
3 trials
Las Vegas, NV
3 trials
Nashville, TN
3 trials
Indianapolis, IN
2 trials
Louisville, KY
2 trials
Sacramento, CA
2 trials
Colorado Springs, CO
1 trials
Fresno, CA
1 trials
New Orleans, LA
1 trials
Virginia Beach, VA
1 trials
Drugs Being Studied for Multiple Sclerosis
Ublituximab8Ocrelizumab7Fingolimod3UCAR T-cell3Fludarabine3Rituximab3Cyclophosphamide3Ozanimod2Clemastine Fumarate2Intravenous steroid2rapcabtagene autoleucel (YTB323)2Methylprednisolone2Orelabrutinib2Metformin2HP 13C pyruvate injection1Ocrelizumab Co-formulated With rHuPH201ATLG administration1Privosegtor1LTX-0021Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)1Optional collection1Blood test and principal collection1Silodosin 8 mg1QT-219CX1
Recently Updated Trials
- A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)Hoffmann-La Roche
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPhase 2PhenoNet, Inc.
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 3Zenas BioPharma (USA), LLC
- Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility DeviceNAUniversity of Illinois at Chicago
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 3Novartis Pharmaceuticals
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemNational Institute of Allergy and Infectious Diseases (NIAID)
- A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)Phase 2Hoffmann-La Roche
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)National Institute of Neurological Disorders and Stroke (NINDS)
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)Phase 1/Phase 2National Institute of Allergy and Infectious Diseases (NIAID)
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisPhase 2Novartis Pharmaceuticals
Frequently Asked Questions
How many Multiple Sclerosis clinical trials are currently recruiting?
There are 541 Multiple Sclerosis clinical trials currently recruiting participants across the United States.
Which states have the most Multiple Sclerosis trials?
The states with the most Multiple Sclerosis clinical trials are California, Texas, Massachusetts.
What phases are Multiple Sclerosis trials in?
Multiple Sclerosis trials span multiple phases: NA (199), Not specified (184), Phase 2 (42).
Can healthy volunteers join Multiple Sclerosis trials?
Most Multiple Sclerosis trials require participants to have the condition. None of the currently recruiting trials explicitly accept healthy volunteers.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.